East Asia & Pacific (excluding high income) vs Luxembourg: Immunization, HepB3
Immunization, HepB3 over time
- East Asia & Pacific (excluding high income)
- Luxembourg
How they compare
Luxembourg currently reports 98.0% against 87.4% in East Asia & Pacific (excluding high income), a difference of 10.6%.
That makes Luxembourg's figure about 1.1 times East Asia & Pacific (excluding high income)'s.
The two have swapped places 6 times across 28 shared years of data; in 1997 it was Luxembourg ahead.
East Asia & Pacific (excluding high income) ranks 16th and Luxembourg ranks 19th of 47 groups.
Luxembourg has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | East Asia & Pacific (excluding high income) | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 19.3% | 58.0% | 38.7% | Luxembourg |
| 2000s | 74.5% | 91.3% | 16.8% | Luxembourg |
| 2010s | 93.7% | 94.5% | 0.8% | Luxembourg |
| 2020s | 89.2% | 97.0% | 7.8% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, East Asia & Pacific (excluding high income) or Luxembourg?
- Luxembourg, at 98.0% against 87.4% in East Asia & Pacific (excluding high income) as of 2024.
- What is the difference in immunization, hepb3 between East Asia & Pacific (excluding high income) and Luxembourg?
- 10.6%, with Luxembourg ahead.
- How many years of comparable data are there for East Asia & Pacific (excluding high income) and Luxembourg?
- 28 years are reported by both, from 1997 to 2024.
- How do East Asia & Pacific (excluding high income) and Luxembourg rank globally for immunization, hepb3?
- East Asia & Pacific (excluding high income) ranks 16th and Luxembourg ranks 19th of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.